Caption Management, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $12.4 Million - $15 Million	14,000 New	14,000 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $7.75 Million - $8.82 Million	10,000 New	10,000 $8.78 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $17.1 Million - $20.8 Million	25,100 New	25,100 $20.6 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $4.26 Million - $5.03 Million	9,000 New	9,000 $5.03 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $804,114 - $986,760	-1,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $860,940 - $1.09 Million	1,800 New	1,800 $869,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $7.4 Million - $9.66 Million	-15,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $5.04 Million - $7.42 Million	15,000 New	15,000 $7.32 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $2.05 Million - $2.39 Million	-7,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $2.25 Million - $3.11 Million	7,500 New	7,500 $2.35 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.